The investigational therapy uses SteadyTeq, a proprietary copolymer technology from Medincell designed to release olanzapine steadily over time
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Hemant Surgical Industries receives order
The facility has been designed with a dual focus on efficiency and sustainability
The agreement complements other PPAs for Sandoz production sites globally
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Subscribe To Our Newsletter & Stay Updated
